Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders.
about
Treating Negative Symptoms in Schizophrenia: an UpdateR-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effectsComparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depressionClinical and biochemical study of d-serine metabolism among schizophrenia patients.Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with KetamineComparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.New targets for rapid antidepressant action.Blockade of interleukin-6 receptor in the periphery promotes rapid and sustained antidepressant actions: a possible role of gut-microbiota-brain axisNovel Glutamatergic Treatments for Severe Mood Disorders.An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity DisorderDepression-like phenotype by deletion of α7 nicotinic acetylcholine receptor: Role of BDNF-TrkB in nucleus accumbens.Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model.Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13).Pushing the threshold: How NMDAR antagonists induce homeostasis through protein synthesis to remedy depression.A Meta-Analysis of Memantine for Depression.Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder.Regional differences in dendritic spine density confer resilience to chronic social defeat stress.Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signaling.Increased EphA4-ephexin1 signaling in the medial prefrontal cortex plays a role in depression-like phenotype.Supplementation with D-serine prevents the onset of cognitive deficits in adult offspring after maternal immune activation.Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammation.Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression.Evaluation of β-Aminocarboxylic Acid Derivatives in Hippocampal Excitatory Synaptic Transmission.Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model.Neurorestorative effect of erythropoietin and environmental enrichment in the early stage of stroke recovery
P2860
Q26744805-3D0C2B18-CF2B-41FA-9240-049C6403F212Q28266846-6CDA1B58-40B7-4AA5-B018-595372C17521Q28277636-5FDDCAE0-067A-4800-8A51-29AC3BC0A569Q33565101-4F26D85A-FF44-4D25-B392-F07F11048F7BQ33614178-05ED1C88-06B0-4FEB-B17D-9199D52B574AQ34492381-8C218AAA-57F2-47F0-9DBF-1E4078E87228Q34507177-CBC0C6E5-D081-481F-B377-2D67E88068D3Q34557243-275CC1DC-D1D4-43CA-A695-F250C83D718BQ36498659-18375821-E742-409C-8A9E-AC8943234895Q36656889-02D2A2D0-F89A-4763-8FA8-FDCFFDD37F37Q37399810-7D08516C-5910-422C-B652-79792164CB46Q37547285-603DD32C-DB73-488F-81F3-252E1B0F8613Q37741989-DC866EE2-A513-4FB3-9FBC-A0E9879FD241Q38820173-3A51B3CE-8237-4CD1-8377-2D4E92AB6F9BQ39145461-74762A0D-2A80-4443-8A20-01139F5F24FEQ39145749-B9D7CBB5-BA74-4E3A-A454-5542CBD4E423Q39307760-77D18879-33C6-48C4-95DA-5B7F277EA2F1Q39494795-38F5FC2A-EC24-422A-9ED7-85B6DA934DA1Q40097393-3ACA909A-2D96-42A2-993B-8C418C908462Q40448883-C48EE2F2-24D8-4235-9687-17E26CB5DD4AQ41903462-5D44E82E-AFDC-4C08-8021-C3ED8A3CBA42Q47401011-E8431CB9-F95C-474F-B0CB-E4781D93F529Q47633542-88CD2E07-F768-415C-A441-8983C4FEF37BQ48034014-6828A44A-1CDC-41F0-901B-8FA7A8D46318Q53441048-4A79D168-C8DA-4005-882A-8CE0F14FCA9CQ58267476-3BBE836A-0E40-4DAA-8CEB-E529270ED49C
P2860
Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glutamate Signaling in Synapto ...... ets for Psychiatric Disorders.
@en
type
label
Glutamate Signaling in Synapto ...... ets for Psychiatric Disorders.
@en
prefLabel
Glutamate Signaling in Synapto ...... ets for Psychiatric Disorders.
@en
P1476
Glutamate Signaling in Synapto ...... ets for Psychiatric Disorders.
@en
P2093
P304
P356
10.2174/1566524015666150330143008
P50
P577
2015-01-01T00:00:00Z